By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Antares Pharma, Inc. 

161 Cheshire Lane
Suite 100
Plymouth  Minnesota  55441  U.S.A.
Phone: 800-328-3074-or-612-475-7700 Fax: 612-476-1009



Company News
Antares Pharma (ATRS) Announces Submission Of New Drug Application For Quickshot Testosterone 12/21/2016 9:11:10 AM
Antares Pharma (ATRS) Announces The Successful Completion Of Teva (TEVA)’s Decentralized Procedure For Teriparatide Injection In Europe 12/19/2016 12:54:30 PM
Antares Pharma (ATRS) Reports Third Quarter 2016 Financial and Operating Results 11/9/2016 8:17:07 AM
Antares Pharma (ATRS) To Report Third Quarter Financial And Operating Results And Host Webcast And Conference Call 11/3/2016 10:51:39 AM
Antares Pharma (ATRS) Appoints Fred M. Powell, Senior Vice President And Chief Financial Officer 10/31/2016 7:54:21 AM
Antares Pharma (ATRS) Announces Completion Of The Quickshot Testosterone Clinical Program 9/22/2016 10:14:42 AM
Antares Pharma (ATRS) To Present At The Ladenburg Thalmann 2016 Healthcare Conference 9/20/2016 8:20:22 AM
Antares Pharma (ATRS) Reports Second Quarter 2016 Operating And Financial Results 8/9/2016 10:56:48 AM
Antares Pharma (ATRS) To Report Second Quarter Financial And Operating Results And Host Webcast And Conference Call 8/2/2016 8:28:58 AM
Teva (TEVA) And Antares Pharma (ATRS) Announce Launch Of Generic Imitrex In The United States 6/27/2016 10:01:53 AM